The insulin-mediated control of sterol-regulatory element binding protein expression in the liver and adipose tissue is central to alterations in lipid metabolism associated with hyperinsulinemia, over-activity of sterol-regulatory element binding protein signaling may lead to dyslipidemia [26]. The gene discussed is INS; the disease is metabolic syndrome.